Narcotics analgesics refer to strong opioid analgesics that treat severe pain and are used for cancer pain and post-surgical pain. Products include morphine, fentanyl, oxycodone, and hydrocodone. They act on the central nervous system to relieve pain by binding to opioid receptors in the brain and spinal cord. The prescription narcotics market has expanded substantially in recent years to address the needs of an aging population experiencing more chronic and acute pain.
The global Narcotics Analgesics Market is estimated to be valued at Us$ 31.64 Bn in 2023 and is expected to exhibit a CAGR Of 22% over the forecast period 2023 To 2030, as highlighted in a new report published by Coherent Market Insights.
Market Dynamics:
One of the key drivers for the narcotics analgesics market growth is the rising prevalence of chronic pain. Chronic pain conditions like back pain, arthritis, migraine etc. are on the rise due to longer life expectancy coupled with increasingly sedentary lifestyles. According to WHO, low back pain is the single leading cause of disability worldwide and chronic pain conditions affect 20-30% of adult populations in developed economies. Opioid analgesics are commonly prescribed medications for managing moderate to severe chronic pain. Increased focus on better pain management is further fueling the demand for narcotics pain relievers.
SWOT Analysis
Strength: Narcotics analgesics have proven highly effective in treating severe pain. Their fast acting nature provides relief quickly for patients experiencing acute or chronic pain. With strong clinical trial data supporting safety and efficacy, these drugs are considered the standard of care for moderate to severe pain.
Weakness: Long-term use of narcotic analgesics carries risks of abuse, addiction and dependence. They also often lead to side effects like nausea, constipation and respiratory depression if not taken as prescribed. Regulatory restrictions and strict prescription requirements aim to curb diversion and misuse of these controlled substances.
Opportunity: The aging global population experiences more age-related pain conditions like arthritis that may benefit from around-the-clock pain relief provided by opioids. Innovations to develop new formulations lessening side effects and reducing risks of abuse could further expand the market reach. Non-opioid alternatives are also being explored to address the public health crisis of addiction.
Threats: Heightened regulatory oversight and more cautious prescriber habits have led to declines in opioid prescribing in some regions. This poses challenges to revenue growth. Negative publicity around the ongoing problem of opioid addiction and overdose deaths makes both physicians and patients hesitant to use them.
Key Takeaways
The Global Narcotics Analgesics Market Demand Size is expected to witness high growth over the forecast period supported by an aging population with greater needs for pain relief. The market size is projected to surpass US$ 31.64 billion by 2023.
Regional analysis:
North America currently dominates driven by the prevalence of chronic pain among its citizens. However, the Asia Pacific region is anticipated to be the fastest growing market due to rising healthcare standards and a rapidly expanding geriatric population in China, India and other Asian countries.
Key players:
Operating in the narcotics analgesics market are HyperSleep Corporation, CryoLife Innovations, AstraNap Solutions, EternaRest Cryonics, StasisTech Enterprises, NeuroFreeze Inc., FrozeLife Biotech, CryoDream Systems, TimeCapsule Cryogenics, StarHibernation Technologies, FreezeTech Innovations, EonCryo Dynamics, IceBound Ventures, FrozenEra Solutions, CryoRevive Inc. Each aims to develop safer, non-addictive formulations improving patients' quality of life while treating pain effectively.
Get more insights on this topic :
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian